You could face higher health insurance premiums next year

Employer-sponsored health insurance costs are projected to rise significantly in the coming year, with consulting firms Mercer and Aon forecasting average increases of 9% and 9.5% respectively for 2026, driven by escalating hospital costs, expensive prescription drugs like GLP-1s, and increased utilization. This represents the largest cost-per-employee increase in over a decade (6-7%), indicating that employers will likely pass on higher premiums, deductibles, or copays to employees, although some may absorb costs in competitive labor markets. The trend underscores a broader acceleration in healthcare spending, which is outpacing general economic growth, posing continued financial pressure on corporations and their workforce.

Analysis

Employer-sponsored health insurance costs are projected to rise significantly, with Mercer forecasting a nearly 9% average increase in 2026 for employers not taking action, and Aon projecting a 9.5% climb next year. Segal estimates a 9% increase for health plans and 11% for prescription drugs, representing the largest cost-per-employee increase (6-7%) in over a decade.

These escalating costs are primarily driven by rising hospital expenses, the increasing price of prescription drugs including GLP-1s, and higher utilization rates partly due to convenient options like telehealth. This trend aligns with broader healthcare spending, which jumped 8.2% in 2024 and is projected to grow another 7.1% this year, consistently outpacing general economic growth.

Corporations will likely pass a substantial portion of these increases onto employees through higher premiums, deductibles, or copays, with the employee share of premiums potentially rising by 6.5%. While some employers in competitive labor markets may absorb costs, the overall trend indicates sustained pressure on corporate profitability and potential erosion of consumer discretionary income, as health insurance costs as a percentage of median family income have already surged from 13% to 25% between 2000 and 2021.

Key Decisions for Investors

• Monitor corporate earnings reports for companies with large U.S. workforces, as rising healthcare expenses could compress profit margins or necessitate higher labor costs to retain talent.
• Evaluate investment opportunities in the healthcare sector, particularly among pharmaceutical companies with high-demand products like GLP-1s and efficient healthcare providers, while also considering potential regulatory responses to cost inflation.
• Assess the potential impact on consumer discretionary spending and broader inflationary trends, given that employees will likely face increased out-of-pocket healthcare costs.